A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

BACKGROUND: Juvenile idiopathic arthritis (JIA) is an inflammatory arthritis of unknown etiology, which lasts for greater than 6 weeks with onset before 16 years of age. JIA is the most common chronic rheumatic disease in children. NSAIDs have been the mainstay of initial management with naproxen (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovell, Daniel J., Dare, Jason A., Francis-Sedlak, Megan, Ball, Julie, LaMoreaux, Brian D., Von Scheven, Emily, Reinhardt, Adam, Jerath, Rita, Alpan, Oral, Gupta, Ramesh, Goldsmith, Donald, Zeft, Andrew, Naddaf, Henry, Gottlieb, Beth, Jung, Lawrence, Holt, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019234/
https://www.ncbi.nlm.nih.gov/pubmed/29941047
http://dx.doi.org/10.1186/s12969-018-0260-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019234/
https://www.ncbi.nlm.nih.gov/pubmed/29941047
http://dx.doi.org/10.1186/s12969-018-0260-y

Ejemplares similares